119 related articles for article (PubMed ID: 12734096)
1. Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells.
Smyth GP; Stapleton PP; Barden CB; Mestre JR; Freeman TA; Duff MD; Maddali S; Yan Z; Daly JM
Ann Surg Oncol; 2003 May; 10(4):455-62. PubMed ID: 12734096
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.
Ménétrier-Caux C; Bain C; Favrot MC; Duc A; Blay JY
Br J Cancer; 1999 Jan; 79(1):119-30. PubMed ID: 10408703
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytokine mRNA transcripts in renal cell carcinoma.
Olive C; Cheung C; Nicol D; Falk MC
Immunol Cell Biol; 1998 Aug; 76(4):357-62. PubMed ID: 9723777
[TBL] [Abstract][Full Text] [Related]
4. An assessment of the immunological status of patients with renal cell carcinoma based on the relative abundance of T-helper 1- and -2 cytokine-producing CD4+ cells in peripheral blood.
Onishi T; Ohishi Y; Goto H; Tomita M; Abe K
BJU Int; 2001 Jun; 87(9):755-9. PubMed ID: 11412209
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
6. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM
Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111
[TBL] [Abstract][Full Text] [Related]
7. Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes.
Maeurer MJ; Martin DM; Castelli C; Elder E; Leder G; Storkus WJ; Lotze MT
Cancer Immunol Immunother; 1995 Aug; 41(2):111-21. PubMed ID: 7656270
[TBL] [Abstract][Full Text] [Related]
8. Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Frankenberger B; Pohla H; Noessner E; Willimsky G; Papier B; Pezzutto A; Kopp J; Oberneder R; Blankenstein T; Schendel DJ
Clin Cancer Res; 2005 Mar; 11(5):1733-42. PubMed ID: 15755994
[TBL] [Abstract][Full Text] [Related]
9. Influence of immunotherapy (IL2 + LAK + inhibition of prostaglandin synthesis) on peripheral blood immune parameters and in vitro cytokine production in metastatic renal cell carcinoma.
Kleinknecht S; Bichler KH; Strohmaier WL
Urol Int; 1993; 50(3):121-8. PubMed ID: 8465478
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 inhibits cyclo-oxygenase-2 expression and prostaglandin E production by human mature dendritic cells.
Teloni R; Giannoni F; Rossi P; Nisini R; Gagliardi MC
Immunology; 2007 Jan; 120(1):83-9. PubMed ID: 17059508
[TBL] [Abstract][Full Text] [Related]
11. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production.
Tsuboi I; Tanaka H; Nakao M; Shichijo S; Itoh K
Cytokine; 1995 May; 7(4):372-9. PubMed ID: 8589268
[TBL] [Abstract][Full Text] [Related]
13. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
[TBL] [Abstract][Full Text] [Related]
14. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures.
McHugh SM; Rifkin IR; Deighton J; Wilson AB; Lachmann PJ; Lockwood CM; Ewan PW
Clin Exp Immunol; 1995 Feb; 99(2):160-7. PubMed ID: 7851006
[TBL] [Abstract][Full Text] [Related]
16. The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype.
Dooper MM; Wassink L; M'Rabet L; Graus YM
Immunology; 2002 Sep; 107(1):152-9. PubMed ID: 12225374
[TBL] [Abstract][Full Text] [Related]
17. Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity.
Liu Z; Smyth FE; Renner C; Lee FT; Oosterwijk E; Scott AM
Cancer Immunol Immunother; 2002 May; 51(3):171-7. PubMed ID: 11941456
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and tissue compartmentalization of the inflammatory response following thermal injury.
Schwacha MG; Schneider CP; Chaudry IH
Cytokine; 2002 Mar; 17(5):266-74. PubMed ID: 12027408
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.
Pyeon D; Diaz FJ; Splitter GA
J Virol; 2000 Jun; 74(12):5740-5. PubMed ID: 10823885
[TBL] [Abstract][Full Text] [Related]
20. Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues.
Fujihashi K; Yamamoto M; Hiroi T; Bamberg TV; McGhee JR; Kiyono H
Clin Exp Immunol; 1996 Mar; 103(3):422-8. PubMed ID: 8608641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
